Enhanced endogenous thrombolysis induced by a specific factor Xa inhibitor, DX-9065a, evaluated in a rat arterial thrombolysis model in vivo.

[1]  K. Oiwa,et al.  Enhanced Thrombolysis Induced by Argatroban or Activated Protein C in the Presence or Absence of Staphylokinase, Measured in an in vivo Animal Model Using Mesenteric Arterioles , 2001, Pathophysiology of Haemostasis and Thrombosis.

[2]  P. Verhallen,et al.  An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model. , 2000, Thrombosis research.

[3]  M. Boffa,et al.  A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis Inhibitor* , 1998, The Journal of Biological Chemistry.

[4]  D. Prasa,et al.  Inhibition of Thrombin Generation in Plasma by Inhibitors of Factor Xa , 1997, Thrombosis and Haemostasis.

[5]  M. Boffa,et al.  Thrombin, Thrombomodulin and TAFI in the Molecular Link Between Coagulation and Fibrinolysis , 1997, Thrombosis and Haemostasis.

[6]  P. A. von dem Borne,et al.  Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis. , 1997, The Journal of clinical investigation.

[7]  J. Giddings,et al.  Adjuvant effect of argatroban on staphylokinase induced thrombolysis of platelet rich thrombi in rat mesenteric venules in vivo. , 1997, Thrombosis research.

[8]  M. Nesheim,et al.  The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent. , 1996, Blood.

[9]  E. Topol,et al.  Inducible carboxypeptidase activity. A role in clot lysis in vivo. , 1996, Circulation.

[10]  H. Ishihara,et al.  DX-9065a, a New Synthetic, Potent Anticoagulant and Selective Inhibitor for Factor Xa , 1994, Thrombosis and Haemostasis.

[11]  J. Hirsh,et al.  The Effect of Thrombin Inhibitors on Tissue Plasminogen Activator Induced Thrombolysis in a Rat Model , 1992, Thrombosis and Haemostasis.

[12]  J. Schneider.  Heparin and the thrombin inhibitor argatroban enhance fibrinolysis by infused or bolus-injected saruplase (r-scu-PA) in rabbit femoral artery thrombosis. , 1991, Thrombosis research.

[13]  Burton E. Sobel,et al.  Relative Efficacy of Antithrombin Compared With Antiplatelet Agents in Accelerating Coronary Thrombolysis and Preventing Early Reocclusion , 1991, Circulation.

[14]  L. Bush,et al.  Prevention of Reocclusion by MCI-9038, a Thrombin Inhibitor, Following t-PA-lnduced Thrombolysis in a Canine Model of Femoral Arterial Thrombosis , 1990, Thrombosis and Haemostasis.

[15]  G. FitzGerald,et al.  Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[16]  K. Mann,et al.  The activation of bovine protein C by factor Xa. , 1989, The Journal of biological chemistry.

[17]  J. Freyssinet,et al.  Activation of human protein C by blood coagulation factor Xa in the presence of anionic phospholipids. Enhancement by sulphated polysaccharides. , 1989, The Biochemical journal.

[18]  M. Iwamoto.  Plasminogen-Plasmin System IX. Specific Binding of Tranexamic Acid to Plasmin , 1975, Thrombosis and Haemostasis.

[19]  P. Klement,et al.  HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY A Novel Approach to Arterial Thrombolysis , 2017 .

[20]  K. Oiwa,et al.  Enhancement of Endogenous Plasminogen Activator-induced Thrombolysis by Argatroban and APC and Its Control by TAFI, Measured in An Arterial Thrombolysis Model In Vivo Using Rat Mesenteric Arterioles , 2002, Thrombosis and Haemostasis.

[21]  J. Meijers,et al.  Regulation of Fibrinolysis in Plasma by TAFI and Protein C Is Dependent on the Concentration of Thrombomodulin , 2001, Thrombosis and Haemostasis.

[22]  C. Hack,et al.  Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor. , 1998, The Journal of clinical investigation.

[23]  J. Giddings,et al.  The antithrombotic effect of synthetic low molecular weight human factor Xa inhibitor, DX-9065a, on He-Ne laser-induced thrombosis in rat mesenteric microvessels. , 1997, Thrombosis research.

[24]  J. Yamamoto,et al.  The antithrombotic effect of low molecular weight synthetic thrombin inhibitors, argatroban and PPACK, on He-Ne laser-induced thrombosis in rat mesenteric microvessels. , 1993, Thrombosis research.